Ireland is home to a high-performing life sciences industry, offering outstanding opportunities for both economic development and public health. Unlike other European countries, however, Ireland does not have a holistic vision for the future of the sector. This is set to change, as the Government has promised to develop a national life sciences strategy. Our European peers have already adopted ambitious strategies to secure the industry and harness its social benefits, coordinating policy across a range of areas from enterprise and investment to research and healthcare. This event series, organised by the Institute of International and European Affairs (IIEA) in partnership with Johnson & Johnson, will explore these questions and more, bringing together Irish and European leaders from industry, public policy, and academia to discuss the right approach for a national life sciences strategy for Ireland. The second event of this series, entitled Developing a Life Sciences Vision for Ireland: Insights from Europe on Health Innovation, will look how Ireland should shape its life sciences strategy through a healthcare lens. The panellists will discuss the case for a coordinated government approach and explore how aligning healthcare policy with sectoral strategy can unleash benefits both for patients and the economy. Based on their experiences at both national and international level, the panellists will examine what other European countries have done to strengthen links between industry and healthcare systems, prepare for future waves of innovation, and how Ireland can use collaboration with the wider health sector to strengthen its position as a global life sciences hub. Panellists: Professor Mary Horgan, Chief Medical Officer at the Department of Health Ann Van Gysel, CEO of Biovia, Belgium Dr Niklas Blomberg, Executive Director of Innovative Health Initiative Gwynne Morley, General Manager at IQVIA Ireland Ronan Glynn, EY Ireland Health Sector Leader.